HK1215384A1 - 種用於治療阿爾茨海默氏症的包含喹諾酮衍生物和多奈呱齊的藥物 - Google Patents

種用於治療阿爾茨海默氏症的包含喹諾酮衍生物和多奈呱齊的藥物

Info

Publication number
HK1215384A1
HK1215384A1 HK16103366.2A HK16103366A HK1215384A1 HK 1215384 A1 HK1215384 A1 HK 1215384A1 HK 16103366 A HK16103366 A HK 16103366A HK 1215384 A1 HK1215384 A1 HK 1215384A1
Authority
HK
Hong Kong
Prior art keywords
donezepil
medicament
alzheimers disease
carbostyril derivative
treating alzheimers
Prior art date
Application number
HK16103366.2A
Other languages
English (en)
Inventor
Heii Arai
Original Assignee
Otsuka Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Otsuka Pharma Co Ltd filed Critical Otsuka Pharma Co Ltd
Publication of HK1215384A1 publication Critical patent/HK1215384A1/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
HK16103366.2A 2007-05-22 2016-03-23 種用於治療阿爾茨海默氏症的包含喹諾酮衍生物和多奈呱齊的藥物 HK1215384A1 (zh)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2007135367 2007-05-22

Publications (1)

Publication Number Publication Date
HK1215384A1 true HK1215384A1 (zh) 2016-08-26

Family

ID=39636992

Family Applications (2)

Application Number Title Priority Date Filing Date
HK10106804.1A HK1140422A1 (zh) 2007-05-22 2010-07-13 種用於治療阿爾茨海默氏症的包含喹諾酮衍生物和多奈哌齊的藥物
HK16103366.2A HK1215384A1 (zh) 2007-05-22 2016-03-23 種用於治療阿爾茨海默氏症的包含喹諾酮衍生物和多奈呱齊的藥物

Family Applications Before (1)

Application Number Title Priority Date Filing Date
HK10106804.1A HK1140422A1 (zh) 2007-05-22 2010-07-13 種用於治療阿爾茨海默氏症的包含喹諾酮衍生物和多奈哌齊的藥物

Country Status (28)

Country Link
US (1) US20100298375A1 (zh)
EP (2) EP2157973B1 (zh)
JP (1) JP5153870B2 (zh)
KR (1) KR101441725B1 (zh)
CN (1) CN101754758B (zh)
AR (1) AR066664A1 (zh)
AU (1) AU2008253977B2 (zh)
BR (1) BRPI0811919A2 (zh)
CA (1) CA2687289C (zh)
CO (1) CO6251249A2 (zh)
CY (1) CY1116683T1 (zh)
DK (1) DK2157973T3 (zh)
ES (1) ES2545959T3 (zh)
HK (2) HK1140422A1 (zh)
HR (1) HRP20150843T1 (zh)
HU (1) HUE025902T2 (zh)
IL (1) IL202053A (zh)
MX (1) MX2009012583A (zh)
MY (1) MY146407A (zh)
NZ (1) NZ581099A (zh)
PL (1) PL2157973T3 (zh)
PT (1) PT2157973E (zh)
RU (1) RU2469723C2 (zh)
SI (1) SI2157973T1 (zh)
TW (2) TWI423802B (zh)
UA (1) UA96633C2 (zh)
WO (1) WO2008143361A1 (zh)
ZA (1) ZA200908202B (zh)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2135607A1 (en) 2008-06-18 2009-12-23 Pharnext Combination of pilocarpin and methimazol for treating Charcot-MarieTooth disease and related disorders
US9387206B2 (en) 2009-11-03 2016-07-12 Pharnext Therapeutic approaches for treating Alzheimer's disease
EP2322163A1 (en) * 2009-11-03 2011-05-18 Pharnext New therapeutics approaches for treating alzheimer disease
US10010515B2 (en) 2011-03-01 2018-07-03 Pharnext Therapeutic approaches for treating Parkinson's disease
US9241933B2 (en) 2011-03-01 2016-01-26 Pharnext Compositions for treating amyotrophic lateral sclerosis
US9248111B2 (en) 2011-03-01 2016-02-02 Pharnext Therapeutic approaches for treating parkinson's disease
DK2560631T3 (da) 2011-03-01 2014-02-10 Pharnext Baclofen- og acamprosat-baseret af neurologiske forstyrrelser
WO2013187075A1 (ja) * 2012-06-15 2013-12-19 公益財団法人先端医療振興財団 軽度認知障害の予防および／または治療剤
WO2015100255A2 (en) * 2013-12-23 2015-07-02 Holaday John W Disposable container for air hydration
EP3459545A4 (en) 2016-05-19 2020-02-26 National Cerebral and Cardiovascular Center MEDICINES FOR PREVENTING AND / OR TREATING DEMENTIA
SG11201909895UA (en) 2017-05-24 2019-11-28 H Lundbeck As Combination of a 5-ht6 receptor antagonist and an acetylcholinesterase inhibitor for use in the treatment of alzheimer's disease in a patient subpopulation carrying apoe4 alleles
CN107602523B (zh) * 2017-09-11 2020-08-18 安徽中医药大学 京尼平类似物、制备方法及其应用
PL237739B1 (pl) 2018-06-06 2021-05-17 Univ Gdanski Genisteina do zastosowania do leczenia choroby Alzheimera
NL2024431B1 (en) 2019-12-11 2021-09-07 Sulfateq Bv Compounds for treatment of alzheimer’s disease

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5535019A (en) 1978-09-01 1980-03-11 Otsuka Pharmaceut Co Ltd Carbostyryl derivative
JPS5649378A (en) 1979-08-25 1981-05-02 Otsuka Pharmaceut Co Ltd Tetrazolylalkoxycarbostyril derivative
FI95572C (fi) * 1987-06-22 1996-02-26 Eisai Co Ltd Menetelmä lääkeaineena käyttökelpoisen piperidiinijohdannaisten tai sen farmaseuttisen suolan valmistamiseksi
JP2574099B2 (ja) 1992-05-21 1997-01-22 大塚製薬株式会社 アレルギー疾患治療剤
JPH10175864A (ja) 1996-12-16 1998-06-30 Otsuka Pharmaceut Co Ltd 慢性閉塞性肺疾患治療剤
US6322525B1 (en) * 1997-08-28 2001-11-27 Visco Technologies, Inc. Method of analyzing data from a circulating blood viscometer for determining absolute and effective blood viscosity
US6428488B1 (en) * 1997-08-28 2002-08-06 Kenneth Kensey Dual riser/dual capillary viscometer for newtonian and non-newtonian fluids
US6322524B1 (en) * 1997-08-28 2001-11-27 Visco Technologies, Inc. Dual riser/single capillary viscometer
US6019735A (en) * 1997-08-28 2000-02-01 Visco Technologies, Inc. Viscosity measuring apparatus and method of use
US6252081B1 (en) * 1998-01-16 2001-06-26 Eisai Co., Ltd. Process for production of donepezil derivative
US6187790B1 (en) * 1999-03-04 2001-02-13 Neal R. Cutler Use of cilostazol for treatment of sexual dysfunction
US6267985B1 (en) * 1999-06-30 2001-07-31 Lipocine Inc. Clear oil-containing pharmaceutical compositions
US6294192B1 (en) * 1999-02-26 2001-09-25 Lipocine, Inc. Triglyceride-free compositions and methods for improved delivery of hydrophobic therapeutic agents
US6484565B2 (en) * 1999-11-12 2002-11-26 Drexel University Single riser/single capillary viscometer using mass detection or column height detection
US6458804B1 (en) * 2001-01-26 2002-10-01 R.T. Alamo Venturesi, Llc Methods for the treatment of central nervous system disorders in certain patient groups
TW200301135A (en) * 2001-12-27 2003-07-01 Otsuka Maryland Res Inst Inc Pharmaceutical compositions comprising a multifunctional phosphodiesterase inhibitor and an adenosine uptake inhibitor
IL150509A (en) * 2002-07-01 2007-07-04 Joseph Kaspi Pharmaceutical preparations containing donafazil hydrochloride
US6743806B2 (en) * 2002-10-23 2004-06-01 Otsuka Pharmaceutical Company, Limited Active oxygen scavenger
FR2848452B1 (fr) * 2002-12-12 2007-04-06 Aventis Pharma Sa Application des inhibiteurs de recapture intestinale des acides biliaires pour la prevention et le traitement de la maladie d'alzheimer
JP2004189706A (ja) * 2002-12-13 2004-07-08 Eisai Co Ltd 高度アルツハイマー型痴呆治療剤
TWI323660B (en) * 2003-02-25 2010-04-21 Otsuka Pharma Co Ltd Pten inhibitor or maxi-k channels opener

Also Published As

Publication number Publication date
HK1140422A1 (zh) 2010-10-15
PT2157973E (pt) 2015-10-14
NZ581099A (en) 2012-03-30
JP2010527993A (ja) 2010-08-19
PL2157973T3 (pl) 2015-12-31
US20100298375A1 (en) 2010-11-25
JP5153870B2 (ja) 2013-02-27
MX2009012583A (es) 2010-03-08
UA96633C2 (uk) 2011-11-25
AU2008253977B2 (en) 2013-08-22
TWI489983B (zh) 2015-07-01
EP2157973B1 (en) 2015-07-15
TW200904428A (en) 2009-02-01
RU2009147456A (ru) 2011-06-27
IL202053A (en) 2016-04-21
ES2545959T3 (es) 2015-09-17
BRPI0811919A2 (pt) 2014-11-18
CA2687289A1 (en) 2008-11-27
CA2687289C (en) 2015-09-15
DK2157973T3 (en) 2015-08-17
WO2008143361A1 (en) 2008-11-27
MY146407A (en) 2012-08-15
IL202053A0 (en) 2010-06-16
HUE025902T2 (en) 2016-05-30
TW201412315A (zh) 2014-04-01
KR101441725B1 (ko) 2014-09-18
HRP20150843T1 (hr) 2015-09-11
KR20100020482A (ko) 2010-02-22
ZA200908202B (en) 2010-07-28
EP2937085B1 (en) 2019-07-10
CY1116683T1 (el) 2017-03-15
CO6251249A2 (es) 2011-02-21
TWI423802B (zh) 2014-01-21
SI2157973T1 (sl) 2015-10-30
CN101754758A (zh) 2010-06-23
AU2008253977A1 (en) 2008-11-27
RU2469723C2 (ru) 2012-12-20
EP2937085A1 (en) 2015-10-28
EP2157973A1 (en) 2010-03-03
AR066664A1 (es) 2009-09-02
CN101754758B (zh) 2012-10-24

Similar Documents

Publication Publication Date Title
HK1215384A1 (zh) 種用於治療阿爾茨海默氏症的包含喹諾酮衍生物和多奈呱齊的藥物
IL197316A0 (en) Buprenophine-wafer for drug substitution therapy
IL202014A0 (en) A synergistic pharmaceutical combination for the treatment of cancer
GB2454555B (en) Alkoxy compounds for disease treatment
PL2787345T3 (pl) Możliwości leczenia choroby Fabry’ego
GB0616299D0 (en) Drug Capsules for dry power inhalers
EP1980271A4 (en) MEDICINE FOR TRANSNASAL ADMINISTRATION
EP2010187A4 (en) CONNECTIONS FOR DISEASES AND FUNCTIONAL DISORDERS
EP2217240A4 (en) METHOD AND COMPOUNDS FOR PREVENTING AND TREATING A TUMOR
ZA200900750B (en) Indazole derivatives for treating HSP90-induced diseases
IL204728A0 (en) Methods and compounds for treating retinol-related diseases
EP2148685A4 (en) METHODS AND COMPOUNDS FOR THERAPY BASED ON VITAMIN D
PL2340809T3 (pl) Lek zawierający fluorochinoliny
GB0719248D0 (en) Compounds and methods for pharmaceutical use
IL197125A0 (en) Drug combinations for treating airway diseases
ZA200808076B (en) Methods for preventing and treating amyloidogenic diseases
GB0701456D0 (en) Treatment for respiratory disease
EP2146726A4 (en) DIHYDROPYRIDINE DERIVATIVE FOR THE TREATMENT OF CANCER OR PRE-ACUTE DISORDER AND OTHER DISORDERS
EP2116538A4 (en) CONDENSED TETRAHYDROQUINOLINE DERIVATIVE AND ITS USE FOR MEDICAL PURPOSES
HK1120034A1 (en) Pharmaceuticals for treating or preventing oral diseases
EP2156320A4 (en) METHOD OF OBTAINING A NEW COMPOUND AND RECONSTRUCTING A MEDICAMENT
EP2077114A4 (en) PHARMACEUTICAL PREPARATION FOR THE TREATMENT OF FIBROMYALGIA
EP2210878A4 (en) THERAPEUTIC AGENT AGAINST TRPV1-MEDIATED DISEASES
HK1144259A1 (en) Medicament for treating or preventing proteinuria
GB0706940D0 (en) Drugs against cancer infectious diseases

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20230520